Thanks, Leslie, and good afternoon to everyone. Revenue for the third quarter of 2024 was $23.6 million, compared with $27.9 million in the second quarter of 2024, and $17.4 million in the third quarter of 2023. To break down our Q3 ‘24 revenue for you by product category, indium phosphide was $6.8 million, reflecting continued demand in data center applications, including AI, as well as passive optical networks. Gallium arsenide was $6.6 million in line with the pullback we expected after the strong growth in Q2. Germanium substrates were $1.6 million, down from the prior quarter, based on our decision to walk away from certain low margin business opportunities. Finally, revenue from our consolidated raw material joint venture companies in Q3 was $8.6 million, based on continued healthy demand. In the third quarter of 2024, revenue from Asia Pacific was 77%, Europe 12%, and North America 11%. The top five customers generated approximately 29.4% of total revenue, and no customer was over the 10% level. Non-GAAP gross margin in the third quarter was 24.3%, compared with 27.6% in Q2 ‘24, and 11.3% in Q3 of 2023. For those who prefer to track results on a GAAP basis, gross margin in the third quarter was 24.0%, compared with 27.4% in Q2 2024, and 10.7% in Q3 of 2023. On to operating expenses. Total non-GAAP operating expense in Q3 was $9.0 million, compared with $8.9 million in Q2 of 2024, and $7.8 million in Q3 of 2023. On a GAAP basis, total operating expense in Q3 of 2024 was $9.1 million, compared with $9.5 million in Q2, and $8.6 million in Q3 of last year. We expect OpEx to be holding up at approximately this level throughout the balance of 2024. Our non-GAAP operating loss for the third quarter of 2024 was $2.6 million, compared with a non -GAAP operating loss in Q2 of $1.2 million and a non -GAAP operating loss of $5.8 million in Q3 of 2023. For reference, our GAAP operating line for the third quarter of 2024 was a loss of $3.4 million compared with an operating loss of $1.9 million in Q2 of 2024 and an operating loss of $6.7 million in Q3 of 2023. Non-operating other income and expense and other items below the operating line for the third quarter of 2024 was a net gain of $469,000. The details can be seen in the P&L included in our press release today. For Q3 2024, we had a non-GAAP net loss of $2.1 million or $0.05 per share compared with a non-GAAP net loss of $800,000 or $0.02 per share in the second quarter of 2024. The non-GAAP net loss of Q3 2023 was $4.9 million or $0.12 per share. On a GAAP basis, net loss in Q3 was $2.9 million or $0.7 per share. In comparison, net loss was $1.5 million or $0.4 per share in the second quarter of 2024. GAAP net loss in Q3 of 2023 was $5.8 million or $0.14 per share. The weighted average basic shares outstanding in Q3 of 2024 was 43.2 million. Cash, cash equivalents and investments decreased by $4.5 million to $38.8 million as of September 30th. By comparison, at June 30th, it was $43.3 million. Depreciation and amortization in the second quarter was $2.3 million. Total stock comp was $0.8 million. Net inventory was up slightly in the second quarter to $86.1 million. This includes inventory added through our recycling program. 36% of the inventory is raw materials and WIP is 61%. Finished goods makes up approximately 3%. Okay, this concludes the discussion of our quarterly financial results. Turning to our plan to list our subsidiary, Tongmei in China, on the STAR Market in Shanghai, let me give you a brief update on the IPO status. We have continued to keep our application current. Last year and part of this year, the total value of the Shanghai Stock Exchange struggled as the China economy slowed and the real estate sector moved down significantly. This trend resulted in much fewer IPOs. It also led to weaker IPO applicants being removed from the in-process category. We are encouraged that Tongmei was not one of those companies. We are still part of the in-process group and it is a much more selective and smaller group than a few years ago. More recently, the substantive stimulus package in China has helped the economy and boosted the total value of the Shanghai Stock Exchange and we believe these movements may be generating positive momentum for IPOs and for Tongmei. We have continued to lead the team with a diligent energy as we think that Tongmei is a good IPO candidate. We'll keep you informed and hope to have good news to deliver to you. With that, I'll turn it over to Dr. Morris Young for a review of our business and markets. Morris?